Uncomplicated drug-induced disseminated exanthemas

Chemical Immunology and Allergy

Volumn 97, Issue , 2012, Pages 79-97

  Bircher, Andreas J ^a,b  

^a Universitatsspital Basel Dermatologie   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ANDROGEN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; CAPTOPRIL; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COUMARIN; DIGOXIN; ESTROGEN; GOLD; HEPATITIS B VACCINE; LOCAL ANESTHETIC AGENT; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PHENYTOIN; PNEUMOCOCCUS VACCINE; PROTEIN TYROSINE KINASE INHIBITOR; SMALLPOX VACCINE; SULFONAMIDE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; XENOBIOTIC AGENT;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADVERSE OUTCOME; ARTICLE; BABOON SYNDROME; BLEEDING; BLISTER; CHRONOLOGY; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EROSION; ERYTHEMA NODOSUM; ERYTHRODERMA; HUMAN; IMMUNITY; INTERSTITIAL GRANULOMATOUS DRUG REACTION; LICHEN PLANUS; PAPULE; PATHOPHYSIOLOGY; PITYRIASIS ROSEA; PRIORITY JOURNAL; PROVOCATION TEST; PSORIASIS; PUSTULE; SKIN BIOPSY; SKIN INFLAMMATION; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; ANTITUBERCULAR AGENTS; CHEMOKINES; CYTOKINES; EXANTHEMA; HISTAMINE ANTAGONISTS; HUMANS; T-LYMPHOCYTES;

EID: 84861433825     PISSN: 16602242     EISSN: 16622898     Source Type: Book Series    
DOI: 10.1159/000335617     Document Type: Article

References (45)

1. Bircher AJ: Approach to the patient with a drug hypersensitivity reaction -clinical perspectives; in Pichler W (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 352-365.
2. Demoly P, Hillaire-Buys D: Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 2004;24:345-356.
3. Bigby M, Jick S, Jick H, Arndt K: Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256:3358-3363.
4. Bigby M: Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-770.
5. Nigen S, Knowles SR, Shear NH: Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003;2:278-299.
6. Yawalkar N: Maculopapular drug eruptions; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 242-250.
7. Schnyder B: Approach to the patient with drug allergy. Med Clin North Am 2010;94:665-679, xv.
8. Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D: Drug Hypersensitivity Reactions: Pathomechanism and Clinical Symptoms; in Pichler WJ, Glover R (eds): Drug Hypersensitivity: Medical Clinics of North America. Philadelphia, Saunders, 2010, vol 94, pp 645-664.
9. Scherer K, Spoerl D, Bircher AJ: Adverse drug reactions to biologics. J Dtsch Dermatol Ges 2010;8: 411-426.
10. Sparsa A, Boulinguez S, Le Brun V, Roux C, Bonnetblanc JM, Bedane C: Acquired ichthyosis with pravastatin. J Eur Acad Dermatol Venereol 2007;21:549-550.
11. Krasovec M, Elsner P, Burg G: Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology 1993;186:248-252.
12. Bircher AJ: Arzneimittelallergie und Haut. Stuttgart, Thieme, 1996.
13. Drago F, Rampini P, Rampini E, Rebora A: Atypical exanthems: morphology and laboratory investigations may lead to an aetiological diagnosis in about 70% of cases. Br J Dermatol 2002;147:255-260.
14. Hausermann P, Harr T, Bircher AJ: Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004;51:297-310.
15. Bircher AJ, Scherer K: Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am 2010;94:711-725.
16. Pirmohamed M: HIV and drug hypersensitivity; in Pichler W (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 84-94.
17. Litt JZ: Litt's Drug Eruptions & Reactions Manual, ed 16. London, Informa Healthcare, 2010.
18. Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear N: Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007;157:934-940.
19. Del Mar Campos-Fernández M, Ponce-de-León-Rosales S, Archer-Dubon C, Orozco-Topete R: Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit. Rev Invest Clin 2005;57:770-774.
20. Sparsa A, Boulinguez S, Le Brun V, Roux C, Bonnetblanc J, Bedane C: Acquired ichthyosis with pravastatin. J Eur Acad Dermatol Venereol 2007;21: 549-550.
21. Proksch E: Lipidsenker-induzierte Nebenwirkungen an der Haut. Hautarzt 1995;46:76-80.
22. Bork K: Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.
23. Drago F, Broccolo F, Rebora A: Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol 2009;61: 303-318.
24. Prantsidis A, Rigopoulos D, Papatheodorou G, Menounos P, Gregoriou S, Alexiou-Mousatou I, Katsambas A: Detection of human herpesvirus 8 in the skin of patients with pityriasis rosea. Acta Derm Venereol 2009;89:604-606.
25. Rongioletti F, Fiorucci C, Parodi A: Psoriasis induced or aggravated by drugs. J Rheumatol 2009; 83:59-61.
26. Ramdial PK, Naidoo DK: Drug-induced cutaneous pathology. J Clin Pathol 2009;62:493-504.
27. Mouräo A, Rustin M, Isenberg D: Exacerbation of psoriatic skin lesions in patients with psoriatic arthritis receiving anti-tumour necrosis factor-alpha therapy: description of 3 cases and review of the literature. Clin Exp Rheumatol 2010;28:408-410.
28. Laquer V, Saedi N, Dann F, Kelly K: Sorafenibassociated psoriasiform skin changes (letter). Cutis 2010;85:301-302.
29. Park J-J, Choi YD, Lee J-B, Kim S-J, Lee S-C, Won YH, Yun SJ: Psoriasiform drug eruption induced by anti-tuberculosis medication: potential role of plasmacytoid dendritic cells. Acta Derm Venereol 2010; 90:305-306.
30. Ellgehausen P, Elsner P, Burg G: Drug-induced lichen planus. Clin Dermatol 1998;16:325-332.
31. Musumeci ML, Lacarrubba F, Micali G: Onset of lichen planus during treatment with etanercept. Am J Clin Dermatol 2010;11:55-56.
32. Van Renterghem D, De Vries EA: Pseudo-lymphoma and anticonvulsant hypersensitivity syndrome during the use of anti-epileptic agents. Tijdschr Geneesk 1997;53:399-403.
33. Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996; 15:250-257.
34. Regula CG, Hennessy J, Clarke LE, Adams DR, Ioffreda MD, Graber EM, Helm KF: Interstitial granulomatous drug reaction to anakinra. J Am Acad Dermatol 2008;59:S25-S27.
35. Vila A, Puig L, Fernández-Figueras M, Laiz A, Vidal D, Alomar A: Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients. Br J Dermatol 2005;153:417-423.
36. Oh S, Schramme A, Stark A, Tilgen W, Gutwein P, Reichrath J: Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin. Br J Dermatol 2008;158:1371-1373.
37. Cohen P: Sweet's syndrome -a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.
38. Thompson DF, Montarella KE: Drug-induced Sweet's syndrome. Ann Pharmacother 2007;41:801-811.
39. van Rooijen MM, Brand CU, Ballmer-Weber BK, Yawalkar N, Hunziker TK: Medikamentös induziertes papulopurpurisches Gloves-and-Socks-Syndrom. Hautarzt 1999;50:280-283.
40. Bircher AJ: The lymphocyte transformation test in drug hypersensitivity. A useful diagnostic tool? in Nicolas JF (ed): Allergie aux médicaments: Tests immuno-biologiques. Montrouge, John Libbey Eurotext, 2006, pp 41-45.
41. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, Brockow K, Pichler WJ, Demoly P: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-863.
42. Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, Campi P, Sanz ML, Castells M, Demoly P, Pichler WJ, for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity: General considerations on rapid desensitization for drug hypersensitivity -a consensus statement. Allergy 2010;65:1357-1366.
43. Scherer K, Bircher AJ: Danger signs in drug hypersensitivity. Med Clin North Am 2010;94:681-689.
44. Bircher AJ: Symptoms and danger signs in acute drug hypersensitivity. Toxicology 2005;209:201-207.
45. Pichler WJ: Drug hypersensitivity reactions: Classification and relationship to T-cell activation; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 168-189.